Vasopressors & The Older Patient - The 65 Trial

April 27, 2020 00:22:04
Vasopressors & The Older Patient - The 65 Trial
Critical Care Perspectives in Emergency Medicine
Vasopressors & The Older Patient - The 65 Trial

Apr 27 2020 | 00:22:04

/

Show Notes

Current guidelines for many critical illnesses recommend targeting a MAP of 65 mm Hg, with consideration of higher MAPs in older patients with chronic HTN. Recent literature, however, suggests increased mortality in older patients who are exposed to larger quantities of vasopressor medications.  In this podcast, we do a deep dive into the recently published 65 Trial, which sought to evaluate the effect of permissive hypotension in older patients with vasodilatory hypotension.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

November 15, 2021 00:28:29
Episode Cover

Hyperkalemia in the ED

Hyperkalemia is a life-threatening electrolyte disorder that is commonly encountered in the ED and ICU.  In this podcast we review the latest evidence in...

Listen

Episode

September 25, 2018 00:24:02
Episode Cover

PARAMEDIC2 - Is Epi Useful in OHCA?

Recent trials have produced conflicting results on the benefit of epinephrine in patients with OHCA.  PARAMEDIC2 was just published and is the largest randomized...

Listen

Episode 0

February 18, 2020 00:19:11
Episode Cover

Roc vs. Sux - The CURASMUR Trial

The debate on the ideal neuromuscular blocking agent for RSI in emergency intubations rages on. In this podcast, we review the latest randomized trial...

Listen